|Articles|October 20, 2021
Characterization of Biomacromolecules by FPLC-MALS
Author(s)Tosoh Bioscience LLC
The coupling of FPLC to MALS not only detects but also quantitatively determines the absolute molecular weight and size of each species, including the targeted molecules, impurities, and its aggregates.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
2
Novel Delivery Approaches of Biopharmaceuticals 2025
3
EMA Director Highlights Agency Achievements in 2025
4
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
5